High level of immunity against poliomyelitis in Albanian refugees in Southern Italy

Journal of Travel Medicine

Volumn 7, Issue 3, 2000, Pages 111-115

  Lopalco, P L ^b   Germinario, C ^b   Calvario, A ^b   Chironna, M ^b   Quarto, Michele ^a   Barbuti, S ^b  

^a UNIVERSITY OF BARI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHILD; DEMOGRAPHY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; POLIOMYELITIS; REFUGEE; VACCINATION;

EID: 0033933266     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2000.00040     Document Type: Article

References (32)

1. Forty-First World Health Assembly. Global eradication of poliomyelitis by the year 2000. Geneva, WHO, WHA 1988; 41:28.
2. Chas Cockburn W. The work of the W.H.O. consultative group on poliomyelitis vaccines. Bull World Health Organ 1988;66(2)-143-154.
3. OMS, Ginevra. Acute flaccid paralysis surveillance, 1992. Wkly Epidemiol Rec 1993; 68(36):264-266.
4. OMS, Ginevra. Expanded Programme on Immunization (EPI). Poliomyelitis eradication: the WHO Global Laboratory Network. Wkly Epidemiol Rec 1997; 72(33):245-249.
5. OMS, Ginevra. Expanded Programme on Immunization (EPI). Progress towards global poliomyelitis eradication 1988-1997. Wkly Epidemiol Rec 1998; 73(22):161-168.
6. OMS, Ginevra. Expanded Programme on Immunization (EPI). Progress toward poliomyelitis eradication 1994-1997. Wkly Epidemiol Rec 1998; 73(8):49-53.
7. Birmingham ME, Aylward RB, Cochi SL, Hull HF. National immunization days: state of the art. J Infect Dis 1997; 175(1): 183-188.
8. De Quardos CA, Andrus JK, Olive JM, Carrasco P. Strategies for poliomyelitis eradication in developing countries. Public Health Rev 1993-94; 21(1-2):65-78.
9. Oblapenko G. Poliomyelitis eradication in Europe: programme and activities. Public Health Rev 1993-94; 21(1-2): 117-127.
10. Wassilak S, Oblapenko G, Dittmann S. Progress in Europe towards the goal of poliomyelitis eradication. Euro Surv 1997; 2(5):39-41.
11. Wassilak S, Oblapenko G, Dittmann S, et al. Poliomyelitis vaccination strategies for Europe. Lancet 1997; 349:437.
12. Oblapenko G, Sutter RW. Status of poliomyelitis eradication in Europe and the Central Asian Republics of the Former Soviet Union. J Infect Dis 1997; 175(Suppl 1):76-81.
13. De Quadros CA, Hersh BS, Olive JM, et al. Eradication of wild poliovirus from the Americas: acute flaccid paralysis surveillance, 1988-1995. J Infect Dis 1997; 175(1):37-42.
14. Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 1997; 46(3):1-25.
15. Santoro R, Lombardi F, Novello F, et al. Serum antibodies to poliomyelitis in Italy. Bull World Health Organ 1984; 62(4):591-595.
16. Fraizzoli G, Sesana PM, Profeta ML. Prevalenza degli anti-corpi neutralizzanti contro il poliovirus dopo 10 e 15 anni dalla somministrazione del vaccino orale tipo Sabin. J Prev Med Hyg 1989; 1:3-4.
17. Bellelli E, Tanzi ML, Bocelli V, et al. Antipoliomyelitis immunity status among a population that was regularly vaccinated 11-12 years before. Eur J Epidemiol 1991; 7(6):605-611.
18. Greco D, Squarcione S, Germinario C, et al. Health response to a large and rapid influx of Albanian refugees in Southern Italy, 1991. Disasters 1993; 16:347-355.
19. Germinario C, Quarto M, Barbuti S, et al. Public Health emergency in Albania. Eur J Public Health 1993; 3:66.
20. Squarcione S, Germinario C, Iandolo E, et al. Seroimmunity to poliomyelitis in an Albanian immigrant population. Vaccine 1992; 10:853-856.
21. Ostvogel PM, van Wijngaarden JK, van der Avoort H, et al. Poliomyelitis outbreak in an unvaccinated community in the Netherlands 1992-93. Lancet 1994; 344:665-670.
22. Strebel PM, Aubert-Combiescu A, Ion-Nedelcu N, et al. Paralytic poliomyelitis in Romania 1984-1992: evidence for a high risk of vaccine associated disease and reintroduction of wild virus infection. Am J Epidemiol 1994; 140:1111-1124.
23. Bothig B, Danes D, Dittmann S. Immunogenicity of oral poliomyelitis vaccine (OPV) against variants of wild poliovirus type 3. Bull World Health Organ 1990; 68(5):597-600.
24. Esteves K. Safety of oral poliomyelitis vaccine: results of a W.H.O. enquiry. Bull World Health Organ 1988; 66(6):739-746.
25. Potential use of new poliomyelitis vaccines: memorandum from a W.H.O. meeting. Bull World Health Organ 1990; 68(5):545-548.
26. Pregliasco F, Minolfi V, Binola S, et al. Poliomelite: vaccinazione ancora attuale. Ann Ig 1994; 6:675-684.
27. Galazka A. Stability of vaccines. WHO EPI/ Gen/89.8, Geneva 1989.
28. CDC, Atlanta. Poliomyelitis outbreak Albania, 1996. Morb Mortal Wkly Rep 1996; 45(38):819-820.
29. Ciofi degli Atti M, Prevots R, Sallabanda A, et al. Polio outbreak in Albania, 1996. Euro Surv 1997; 2(5):37-39.
30. Prevots DR, Ciofi degli Atti ML, Sallabanda A, et al. Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. Clin Infect Dis 1998; 26(2):419-425.
31. Oberhofer TR, Brown GC, Monto AS. Seroimmunity to poliomyelitis in an American community. Am J Epidemiol 1975; 101:333-339.
32. World Health Organization. Expanded Programme on Immunization (WHO-EPI-CDC-Polio-90.1). Manual for the Virological Investigation of Poliomyelitis. Geneva; WHO, 1990; 44-65.